GLUFALL-G2 contains Glimpride 2Mg + Metformin 500 Mg SR Tablet , a combination oral antidiabetic formulation containing glimepiride and sustained-release metformin. Glimepiride belongs to the sulfonylurea group and works by promoting insulin release from the pancreas, while metformin helps reduce glucose production in the liver and supports better insulin sensitivity. The sustained-release formulation gradually releases metformin over an extended period. Doctors may prescribe it as part of a comprehensive Type 2 diabetes management plan alongside an appropriate diet, regular exercise, and medical supervision.
Indications
- Type 2 Diabetes Mellitus.
- Elevated blood glucose levels.
- Inadequate control through diet and exercise alone.
- Patients requiring combination antidiabetic therapy.
- Glycemic management as prescribed by a physician.
Key Benefits
- Helps maintain blood glucose levels.
- Supports effective insulin activity.
- Reduces excess glucose production.
- Provides sustained metformin action.
- Supports long-term diabetes management.
